Trametinib Dimethyl Sulfoxide
FDA Approved: * August 6, 2024Pharm Company: * NOVUGEN
Category: Cancer
Trametinib (trade name Mekinist & Meqsel both by Novartis ) is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity.[1]It inhibits MEK1 and MEK2.[1] Trametinib had good results for metastatic melanoma carrying the BRAF V600E mutation in a phase III clinical trial. In this mutation, the amino acid valine (V) at position 600 within the BRAF protein has become replaced by glutamic acid (E) making the mutant BRAF protein constitutively active.&a... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Related Brands
Drugs with the same active ingredientsPopular Topics
Well, just out of the blue is it safe to mix Dimethyl sulfoxide(DMSO) 70% and Hydromorphone..or not? i understand DMSO i...
1 REPLYMy 21 month old grandson was born with NF1 and has siginificant plexiform nonmalignant tumors especially of concern on h...
1 REPLYA-167 terquize and white capsule ## Capsule Image The more common term for this is Phentermine, brand name Ionamin. This...
1 REPLYwe want to know about this chimical.our customer has demand from germany...
1,3 Dimethylamylamine...